Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera
Alberto Álvarez‐Larrán(Hospital Clínic de Barcelona), Carles Besses(Hospital Del Mar), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Eduardo Arellano‐Rodrigo(Vall d'Hebron Hospital Universitari), Anabel Teruel(Hospital Clínico Universitario de Valencia), Vicente Vicente(Centro Regional de Hemodonación), Arturo Pereira, Anna Angona(Hospital Del Mar), Begoña Muiña(Hospital General Universitario Morales Meseguer), Beatríz Bellosillo(Universitat Pompeu Fabra), Juan Carlos Hernández‐Boluda(Hospital Clínico Universitario de Valencia), Carmen Burgaleta(Universidad de Alcalá), Montse Gómez(Hospital Clínico Universitario de Valencia), Helga Guillén(Hospital Universitario Príncipe de Asturias), Francisca Ferrer‐Marín(Centre for Biomedical Network Research on Rare Diseases)
Cited by 225
Related Papers
Platelet receptors and signaling in the dynamics of thrombus formation
|Haematologica|2009|409
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
|Leukemia|2008|354